A Case Report Published in Frontiers in Veterinary Science
Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – April 29, 2022) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the „Company“ or „Innocan“) is proud to announce the publication of a case report regarding its compassionate care liposomal-CBD formulation (Innocan’s LPT platform) (the „Treatment„)…